Mikhail Eydelman - Jun 7, 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
SVP, Gen Counsel & Corp Sec
Signature
Mikhail Eydelman, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Jun 7, 2022
Transactions value $
$0
Form type
4
Date filed
6/9/2022, 04:43 PM
Previous filing
May 11, 2022
Next filing
Jan 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Award $0 +7.5K $0.00 7.5K Jun 7, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on June 7, 2023 and 12.5% of the shares every six months thereafter.